Pharmaceutical Patent
Pioneering Solutions in Drug Development.
Invention Patents
Innovative preparation methods for APIs and intermediates.
Utility Model Patents
Innovation and creation of pharmaceutical facilities and equipment.
Autonomous Patent Authorization
Independent ownership and control of patent rights.
Development of New Product
Implementation and improvement of production processes and methods.
Product Process Improvement
Improvement of existing product processes to meet more detailed needs.
Innovation Project Research
Host and conduct provincial-level technology innovation project research.
Patents in Pharmaceutical Industry
“We are committed to protecting our innovations through pharmaceutical
patents while ensuring that they benefit a wider patient population.”
Patents are the Cornerstone of Innovation in the Pharmaceutical Industry
We are well aware that every patent is a commitment to human health and an exploration of future possibilities. We are proud to announce that we have successfully transformed 27 invention patents and 40 new patents, which have not only promoted the progress of medical technology, but also benefited patients.
What did we do?
What's News
Latest News at Tianming
Incoming QC: 3 Checks That Stop Bad Batches on Arrival
A supplier COA is a declaration, not proof. Run incoming QC on arrival: seven checks that decide whether to release or reject a batch.
5 Costly RFQ Mistakes That Inflate Your Intermediate Quote
A vague request for quotation invites an inflated, inaccurate intermediate quote. This buyer’s guide shows the five costly RFQ mistakes that drive prices up and bids apart, and how to write an inquiry that gets comparable, honest quotes from pharmaceutical intermediate suppliers.
Who Calibrated Your Supplier’s HPLC? 7 Costly Hidden Risks
Every assay value on a COA is measured against a reference standard — if that standard is weak, every number built on it is weak. This guide explains the primary-to-working traceability chain and the seven costly mistakes buyers make when they never ask about standards.